USA - NASDAQ:QIPT - CA74880P1045 - Common Stock
The current stock price of QIPT is 2.32 USD. In the past month the price decreased by -11.79%. In the past year, price decreased by -11.79%.
|  Symbol  |  Company Name  |  TA  |  FA  |  PE  |  Market Cap  | 
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.2 | 97.27B | ||
| CI | THE CIGNA GROUP | 8.7 | 65.96B | ||
| LH | LABCORP HOLDINGS INC | 15.95 | 20.97B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 203.73 | 19.85B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.01 | 19.65B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.27 | 15.66B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.52B | ||
| HIMS | HIMS & HERS HEALTH INC | 55.08 | 9.96B | ||
| DVA | DAVITA INC | 12.24 | 8.49B | ||
| CHE | CHEMED CORP | 20.66 | 6.62B | ||
| RDNT | RADNET INC | 211.39 | 5.85B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 59.62 | 5.81B | 
 Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. The company is headquartered in Wilder, Kentucky. The company went IPO on 2014-03-18. The firm's expertise spans across a full spectrum of respiratory care, providing an end-to-end solution for medical providers and patients. This includes technology enabled equipment offerings and specialized care for patients with cardio and pulmonary diseases, sleep disorders, mobility challenges, and other chronic disease management. The firm's healthcare products and services include sleep apnea and pap treatment, home medical equipment, home ventilation and custom mobility solutions. The company has a 60% ownership interest in Hart Medical Equipment, which maintains strategic relationships with integrated health systems and freestanding community-based hospitals, embedding the business into the hospital discharge processes of more than 19 hospitals and affiliated care facilities across its network.
QUIPT HOME MEDICAL CORP
1019 Town Drive
Wilder KENTUCKY US
CEO: Gregory Crawford
Employees: 1200
Phone: 18598782220
Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. The company is headquartered in Wilder, Kentucky. The company went IPO on 2014-03-18. The firm's expertise spans across a full spectrum of respiratory care, providing an end-to-end solution for medical providers and patients. This includes technology enabled equipment offerings and specialized care for patients with cardio and pulmonary diseases, sleep disorders, mobility challenges, and other chronic disease management. The firm's healthcare products and services include sleep apnea and pap treatment, home medical equipment, home ventilation and custom mobility solutions. The company has a 60% ownership interest in Hart Medical Equipment, which maintains strategic relationships with integrated health systems and freestanding community-based hospitals, embedding the business into the hospital discharge processes of more than 19 hospitals and affiliated care facilities across its network.
The current stock price of QIPT is 2.32 USD. The price decreased by -3.33% in the last trading session.
QIPT does not pay a dividend.
QIPT has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on QIPT.
QUIPT HOME MEDICAL CORP (QIPT) currently has 1200 employees.
ChartMill assigns a technical rating of 3 / 10 to QIPT. When comparing the yearly performance of all stocks, QIPT is a bad performer in the overall market: 76.76% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to QIPT. QIPT has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months QIPT reported a non-GAAP Earnings per Share(EPS) of -0.21. The EPS decreased by -90.91% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.35% | ||
| ROE | -10.01% | ||
| Debt/Equity | 0.71 | 
11 analysts have analysed QIPT and the average price target is 3.75 USD. This implies a price increase of 61.57% is expected in the next year compared to the current price of 2.32.
For the next year, analysts expect an EPS growth of -64.33% and a revenue growth -7.25% for QIPT